Skip to content
Tenfell
Awarded contract
Published 18 Sep 2017

NHS Framework Agreement for Proprietary Pharmaceuticals - South of England (Tranche A)

NHS England · London

Key facts

Awarded
10 Aug 2017
Contract starts
31 Aug 2017
Contract ends
31 Aug 2021
Procedure
Open procedure
Buyer type
Central government

Awarded to 22 suppliers

SupplierValue
Janssen-Cilag Ltd—
Pfizer Ltd—
Teva UK Ltd—
Abbvie Ltd—
Amgen Ltd—
Chugai Pharma Uk Ltd—
Sandoz Ltd—
Accord-UK Ltd—
Eli Lilly & Company Ltd—
Gilead Sciences Limited—
Ipsen—
Merck Serono Limited—
Novo Nordisk—
Roche Products Ltd—
ViiV Healthcare UK Ltd—
Ferring Pharmaceuticals Limited—
Pharmacosmos UK Ltd—
Vifor Pharma UK Limited—
Bristol-Myers Squibb Pharmaceuticals Ltd—
Allergan Limited—
Organon Pharma (UK) Ltd.—
Merz Pharma UK Ltd—

Description

An open procurement exercise has been conducted to supply proprietary pharmaceuticals to participatingsecondary care trusts in the South of England.

Whilst this framework agreement is intended for use by the NHS in England. The framework may also be usedby private sector contractors and agents working on behalf of the NHS in England.

Additional information: Note regarding publication of the resulting framework agreement: - The template framework agreement has been published as an attachment to this notice; - Redacted award schedules (i.e. schedule 6) have been included for each successful supplier.

For ease of undersatnding the temaplate framework aggreement has been attached.

An award shedlue for each sussfull has been attached

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.